Geneoscopy
St. Louis, United States · Biotechnology, Healthcare, Health Care · 63 employees
Geneoscopy is a life sciences company with the mission to empower patients and providers to transform gastrointestinal health through innovative diagnostics. Geneoscopy’s lead diagnostic uses stool-derived eukaryotic RNA (seRNA) to detect colorectal cancer and precancerous adenomas. This device was awarded a Breakthrough Device Designation from the FDA for its ability to reduce morbidity associate
Funding history
- Series series c — $105.0M — Jan 2025
- Funding Round — $50.5M — Nov 2021
- Funding Round — $105.0M — Nov 2021
- Funding Round — $7.9M — Sep 2019
Recent signals
- Apr 02, 2025: Geneoscopy Appoints Amit Bhalla as Chief Financial Officer
- Jan 08, 2025: Raised $105.0M in Series series c
- May 15, 2024: Geneoscopy Appoints Matt Sargent as Chief Commercial Officer and Tyler Aldredge as Vice President of Operations
- Nov 19, 2021: Raised $50.5M
- Nov 16, 2021: Raised $105.0M
- Sep 30, 2019: Raised $7.9M
See plans & pricing → Track Geneoscopy ’s funding, hiring, and signals — with verified contacts — on Fundz.